Bisphosphonates in Clinical Oncology: The Development of Pamidronate
This book provides a clinically oriented overview on the patho-physiological background and the use of bisphosphonates in oncology. The clinical development of pamidronate to treat tumor-induced hypercalcemia and malignant osteolytic bone disease is demonstrated, as well as the results of pivotal st...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1999
|
| Series: | Recent Results in Cancer Research
149 |
| Subjects: | |
| Online Access: | UBR01 Volltext |
| Summary: | This book provides a clinically oriented overview on the patho-physiological background and the use of bisphosphonates in oncology. The clinical development of pamidronate to treat tumor-induced hypercalcemia and malignant osteolytic bone disease is demonstrated, as well as the results of pivotal studies. New important findings on how to best use pamidronate in certain indications are given and put in perspective. The author discusses patient management guidelines as well as pharmaco-economic aspects important for the readers |
| Physical Description: | 1 Online-Ressource (XIV, 113 p) |
| ISBN: | 9783642598456 |
| DOI: | 10.1007/978-3-642-59845-6 |
Staff View
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046144759 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1999 |||| o||u| ||||||eng d | ||
| 020 | |a 9783642598456 |9 978-3-642-59845-6 | ||
| 024 | 7 | |a 10.1007/978-3-642-59845-6 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-59845-6 | ||
| 035 | |a (OCoLC)1119136159 | ||
| 035 | |a (DE-599)BVBBV046144759 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XH 7665 |0 (DE-625)152943:13144 |2 rvk | ||
| 100 | 1 | |a Thürlimann, Beat |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Bisphosphonates in Clinical Oncology |b The Development of Pamidronate |c by Beat Thürlimann |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1999 | |
| 300 | |a 1 Online-Ressource (XIV, 113 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Recent Results in Cancer Research |v 149 | |
| 520 | |a This book provides a clinically oriented overview on the patho-physiological background and the use of bisphosphonates in oncology. The clinical development of pamidronate to treat tumor-induced hypercalcemia and malignant osteolytic bone disease is demonstrated, as well as the results of pivotal studies. New important findings on how to best use pamidronate in certain indications are given and put in perspective. The author discusses patient management guidelines as well as pharmaco-economic aspects important for the readers | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Gynecology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Internal medicine | |
| 650 | 4 | |a Gynecology | |
| 650 | 0 | 7 | |a Pamidronsäure |0 (DE-588)4242256-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Osteolyse |0 (DE-588)4210410-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hyperkalzämie |0 (DE-588)4239846-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Knochenkrebs |0 (DE-588)4031331-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Diphosphonate |0 (DE-588)4150083-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Knochenmetastase |0 (DE-588)4164290-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Hyperkalzämie |0 (DE-588)4239846-0 |D s |
| 689 | 0 | 2 | |a Pamidronsäure |0 (DE-588)4242256-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Osteolyse |0 (DE-588)4210410-5 |D s |
| 689 | 1 | 2 | |a Pamidronsäure |0 (DE-588)4242256-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Knochenkrebs |0 (DE-588)4031331-1 |D s |
| 689 | 2 | 1 | |a Diphosphonate |0 (DE-588)4150083-0 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Knochenmetastase |0 (DE-588)4164290-9 |D s |
| 689 | 3 | 1 | |a Pamidronsäure |0 (DE-588)4242256-5 |D s |
| 689 | 3 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642641480 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540636892 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642598463 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-59845-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524944 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-642-59845-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1804180480573046784 |
|---|---|
| any_adam_object | |
| author | Thürlimann, Beat |
| author_facet | Thürlimann, Beat |
| author_role | aut |
| author_sort | Thürlimann, Beat |
| author_variant | b t bt |
| building | Verbundindex |
| bvnumber | BV046144759 |
| classification_rvk | XH 7665 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-59845-6 (OCoLC)1119136159 (DE-599)BVBBV046144759 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-59845-6 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03352nmm a2200745zcb4500</leader><controlfield tag="001">BV046144759</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1999 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642598456</subfield><subfield code="9">978-3-642-59845-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-59845-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-59845-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119136159</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144759</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 7665</subfield><subfield code="0">(DE-625)152943:13144</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Thürlimann, Beat</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bisphosphonates in Clinical Oncology</subfield><subfield code="b">The Development of Pamidronate</subfield><subfield code="c">by Beat Thürlimann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 113 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Recent Results in Cancer Research</subfield><subfield code="v">149</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book provides a clinically oriented overview on the patho-physiological background and the use of bisphosphonates in oncology. The clinical development of pamidronate to treat tumor-induced hypercalcemia and malignant osteolytic bone disease is demonstrated, as well as the results of pivotal studies. New important findings on how to best use pamidronate in certain indications are given and put in perspective. The author discusses patient management guidelines as well as pharmaco-economic aspects important for the readers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Osteolyse</subfield><subfield code="0">(DE-588)4210410-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperkalzämie</subfield><subfield code="0">(DE-588)4239846-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Knochenkrebs</subfield><subfield code="0">(DE-588)4031331-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diphosphonate</subfield><subfield code="0">(DE-588)4150083-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Knochenmetastase</subfield><subfield code="0">(DE-588)4164290-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hyperkalzämie</subfield><subfield code="0">(DE-588)4239846-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Osteolyse</subfield><subfield code="0">(DE-588)4210410-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Knochenkrebs</subfield><subfield code="0">(DE-588)4031331-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Diphosphonate</subfield><subfield code="0">(DE-588)4150083-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Knochenmetastase</subfield><subfield code="0">(DE-588)4164290-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Pamidronsäure</subfield><subfield code="0">(DE-588)4242256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642641480</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540636892</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642598463</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-59845-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524944</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-59845-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV046144759 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:26Z |
| institution | BVB |
| isbn | 9783642598456 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524944 |
| oclc_num | 1119136159 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XIV, 113 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| series2 | Recent Results in Cancer Research |
| spelling | Thürlimann, Beat Verfasser aut Bisphosphonates in Clinical Oncology The Development of Pamidronate by Beat Thürlimann Berlin, Heidelberg Springer Berlin Heidelberg 1999 1 Online-Ressource (XIV, 113 p) txt rdacontent c rdamedia cr rdacarrier Recent Results in Cancer Research 149 This book provides a clinically oriented overview on the patho-physiological background and the use of bisphosphonates in oncology. The clinical development of pamidronate to treat tumor-induced hypercalcemia and malignant osteolytic bone disease is demonstrated, as well as the results of pivotal studies. New important findings on how to best use pamidronate in certain indications are given and put in perspective. The author discusses patient management guidelines as well as pharmaco-economic aspects important for the readers Oncology Internal Medicine Gynecology Oncology Internal medicine Pamidronsäure (DE-588)4242256-5 gnd rswk-swf Osteolyse (DE-588)4210410-5 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Hyperkalzämie (DE-588)4239846-0 gnd rswk-swf Knochenkrebs (DE-588)4031331-1 gnd rswk-swf Diphosphonate (DE-588)4150083-0 gnd rswk-swf Knochenmetastase (DE-588)4164290-9 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Hyperkalzämie (DE-588)4239846-0 s Pamidronsäure (DE-588)4242256-5 s DE-604 Osteolyse (DE-588)4210410-5 s Knochenkrebs (DE-588)4031331-1 s Diphosphonate (DE-588)4150083-0 s Knochenmetastase (DE-588)4164290-9 s Erscheint auch als Druck-Ausgabe 9783642641480 Erscheint auch als Druck-Ausgabe 9783540636892 Erscheint auch als Druck-Ausgabe 9783642598463 https://doi.org/10.1007/978-3-642-59845-6 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Thürlimann, Beat Bisphosphonates in Clinical Oncology The Development of Pamidronate Oncology Internal Medicine Gynecology Oncology Internal medicine Pamidronsäure (DE-588)4242256-5 gnd Osteolyse (DE-588)4210410-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Hyperkalzämie (DE-588)4239846-0 gnd Knochenkrebs (DE-588)4031331-1 gnd Diphosphonate (DE-588)4150083-0 gnd Knochenmetastase (DE-588)4164290-9 gnd |
| subject_GND | (DE-588)4242256-5 (DE-588)4210410-5 (DE-588)4073781-0 (DE-588)4239846-0 (DE-588)4031331-1 (DE-588)4150083-0 (DE-588)4164290-9 (DE-588)4143413-4 |
| title | Bisphosphonates in Clinical Oncology The Development of Pamidronate |
| title_auth | Bisphosphonates in Clinical Oncology The Development of Pamidronate |
| title_exact_search | Bisphosphonates in Clinical Oncology The Development of Pamidronate |
| title_full | Bisphosphonates in Clinical Oncology The Development of Pamidronate by Beat Thürlimann |
| title_fullStr | Bisphosphonates in Clinical Oncology The Development of Pamidronate by Beat Thürlimann |
| title_full_unstemmed | Bisphosphonates in Clinical Oncology The Development of Pamidronate by Beat Thürlimann |
| title_short | Bisphosphonates in Clinical Oncology |
| title_sort | bisphosphonates in clinical oncology the development of pamidronate |
| title_sub | The Development of Pamidronate |
| topic | Oncology Internal Medicine Gynecology Oncology Internal medicine Pamidronsäure (DE-588)4242256-5 gnd Osteolyse (DE-588)4210410-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Hyperkalzämie (DE-588)4239846-0 gnd Knochenkrebs (DE-588)4031331-1 gnd Diphosphonate (DE-588)4150083-0 gnd Knochenmetastase (DE-588)4164290-9 gnd |
| topic_facet | Oncology Internal Medicine Gynecology Oncology Internal medicine Pamidronsäure Osteolyse Krebs Medizin Hyperkalzämie Knochenkrebs Diphosphonate Knochenmetastase Aufsatzsammlung |
| url | https://doi.org/10.1007/978-3-642-59845-6 |
| work_keys_str_mv | AT thurlimannbeat bisphosphonatesinclinicaloncologythedevelopmentofpamidronate |